Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Cardiovasc J Afr ; 27(4): e1-e6, 2016 Aug 23.
Article in English | MEDLINE | ID: mdl-27841915

ABSTRACT

OBJECTIVE: We aimed to assess the management of hypertensive patients by general practitioners in Cotonou city. METHODS: This was a cross-sectional study based on a multicentre survey conducted from 1 May to 31 July 2011. We recruited all consenting general practitioners who worked in public and private centres in Cotonou city. We used the 7th report of the Joint National Committee to assess the management of hypertension by general practitioners. A tested and validated self-questionnaire was used to collect the data on hypertension management by general practitioners. RESULTS: In eight centres that approved the study, 41 general practitioners were included. The definition of hypertension was known by 20 (48.8%) practitioners. Only 25 (61.0%) could describe the conditions for blood pressure measurement. Ten of them were unable to list half of the minimum recommended tests for hypertension, and the majority (92.7%) did not have any idea of global cardiovascular risk. The blood pressure goal was known by only 18 (43.9%) practitioners. Lifestyle (82.9%) and monotherapy (70.7%) were the therapeutic modalities most prescribed. Antihypertensive agents commonly used by practitioners were calcium channel blockers (82.9%), angiotensin converting enzyme inhibitors (53.7%) and diuretics (36.6%). The general practitioners referred their patients to cardiologists mainly for uncontrolled hypertension (63.4%) and the onset of acute complications (56.1%). CONCLUSION: The general practitioners' knowledge of hypertension was insufficient and their management did not reflect international guidelines.


Subject(s)
Antihypertensive Agents/therapeutic use , Attitude of Health Personnel , Blood Pressure/drug effects , General Practitioners/psychology , Health Knowledge, Attitudes, Practice , Hypertension/drug therapy , Benin , Cross-Sectional Studies , Guideline Adherence , Health Care Surveys , Humans , Hypertension/diagnosis , Hypertension/physiopathology , Practice Guidelines as Topic , Practice Patterns, Physicians' , Referral and Consultation , Treatment Outcome , Urban Health
2.
Cardiovasc J Afr ; 26(2): e6-8, 2015 Mar 23.
Article in English | MEDLINE | ID: mdl-25938498

ABSTRACT

Tricuspid infective endocarditis is rare and represents five to 10% of all cases of infective endocarditis. It occurs predominantly in intravenous drug users, and patients with central venous catheters or intracardiac probes. We report on the case of subacute tricuspid infective endocarditis in a girl of 17 years. She had no particular cardiovascular history. She was admitted for a persistent fever with cachexy, cough and thoracic pains, and right heart failure that appeared one month after a clandestine abortion. Transthoracic echocardiography found several vegetations on the tricuspid valve with massive tricuspid regurgitation. The chest X-ray showed bilateral excavated lung abscesses and condensation areas. Blood culture was not done and broad-spectrum antibiotic therapy was given. She was apyretic after 10 days. However, the massive tricuspid regurgitation with right heart failure persisted. She was discharged from hospital after 40 days of treatment. Although rare, infective endocarditis is one of the more serious complications of gynaecological procedures, particularly clandestine abortion. Therefore any young girl with persistent fever must be suspected of clandestine abortion.


Subject(s)
Endocarditis/diagnosis , Tricuspid Valve Insufficiency/diagnosis , Tricuspid Valve/pathology , Abortion, Induced/adverse effects , Adolescent , Ceftizoxime/administration & dosage , Ceftizoxime/analogs & derivatives , Ciprofloxacin/administration & dosage , Echocardiography , Endocarditis/drug therapy , Endocarditis/etiology , Female , Humans , Metronidazole/administration & dosage , Radiography, Thoracic , Tricuspid Valve/diagnostic imaging , Tricuspid Valve Insufficiency/drug therapy , Tricuspid Valve Insufficiency/etiology , Cefpodoxime
SELECTION OF CITATIONS
SEARCH DETAIL
...